Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education

NCT07678450 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-09
Last updated
2026-07-01

Condition(s) studied

Nursing Process

Investigational drug(s) / intervention(s)

Pecha Kucha-Supported MicroteachingTraditional Teaching

Pecha Kucha-Supported Microteaching: Nursing students first received a brief refresher lecture on the nursing process. The experimental group, consisting of 50 students, was then divided into five groups of 10 students each. Each group was assigned a case scenario and a nursing diagnosis. Students were asked to prepare a presentation using the Pecha Kucha-supported microteaching method based on the assigned case and nursing diagnosis. One student from each group delivered the presentation on behalf of the group. Feedback sessions were conducted following the presentations. Subsequently, students prepared individual nursing care plans for patients cared for during clinical practice.

Traditional Teaching: Nursing students first received a brief refresher lecture on the nursing process. The control group, consisting of 50 students, was then divided into five groups of 10 students each. Each group was assigned a case scenario and a nursing diagnosis. Students were asked to collaboratively prepare a nursing care plan based on the assigned case and nursing diagnosis. Following this activity, students prepared individual nursing care plans for patients cared for during clinical practice.

Study summary

This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students. Participants will be randomly assigned to either an intervention group receiving Pecha Kucha-supported microteaching or a control group receiving traditional instruction. The effects of the intervention on nursing process competencies and learning motivation will be evaluated.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * First-year nursing students * Successfully completed prerequisite nursing courses * Grade point average (GPA) of 1.80 or higher * Voluntary agreement to participate in the study * Providing written informed consent Exclusion Criteria: * Students repeating the course * Graduates of Vocational School of Health Services programs * Withdrawal from the study at any stage * Failure to complete study assessments or data collection forms

Primary outcome measure(s)

  • Quality of Nursing Diagnoses, Interventions and Outcomes — After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
    The quality of nursing care plans will be evaluated using the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument. The Q-DIO is a 29-item instrument designed to assess the quality of nursing documentation, including nursing diagnoses, nursing interventions, and nursing-sensitive patient outcomes. The instrument consists of four domains: Nursing Diagnoses as Process, Nursing Diagnoses as Outcomes, Nursing Interventions, and Nursing-Sensitive Patient Outcomes. Higher scores indicate higher quality and more comprehensive documentation of nursing diagnoses, interventions, and patient outcomes in nursing care plans.

Trial sites (1)

FacilityCityRegionStatus
Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing Istanbul Avcılar
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07678450 on ClinicalTrials.gov ↗ ← All trials in Turkey